Financial CONMED CORPORATION (NASDAQ:CNMD) GIVEN RATING OF 2.29 BY ANALYSTS byJosh SandbergSeptember 15, 2015
Financial Oppenheimer: Time To Buy ConforMIS, Two Catalysts Are Coming Next Year Read more byJosh SandbergJuly 27, 2015
Financial Recon Analysts Set CONMED Target Price at $53.60 (NASDAQ:CNMD) byJosh SandbergApril 29, 2015
Recon Global Minimally Invasive Surgical Instruments Market 2015-2019: Medtronic, Smith & Nephew, Aesculap, Ethicon & Stryker Dominates the $14 Billion Industry byJosh SandbergFebruary 24, 2015
Financial Spine Brokerages Expect K2M Group Holdings to Post ($0.33) Earnings Per Share (NASDAQ:KTWO) byJosh SandbergFebruary 23, 2015
Financial Recon Spine Venture Capital Dollars Invested in Life Sciences Companies in 2014 at Highest Level Since 2007, According to the MoneyTree Report byJosh SandbergFebruary 13, 2015
